The term “glycobiology” may be unfamiliar to many students, as it is an undertaught but extremely important field that is linked to nearly every facet of cellular biology. Glycobiology is the study of carbohydrates, also known as glycans. On this exciting episode of Let’s Talk Chemistry edited by David Alvia, hosts Erin Suh, Jasmine Winter, and Diya Garrepally dive into our interview with Dr. Lance Wells. Dr. Wells shares his research on XLID, an intellectual disability syndrome linked to mutations in OGT, an enzyme that adds a type of glycan, called O-GlcNAc, onto proteins. He also shares how glycans can be used to modify drugs through a process called glycosylation to make them more effective. We hope you enjoy!
Chin Huang, a graduate student in Dr. Kelley Moremen’s BioF:GREAT laboratory, has developed a web-based tool that helps glycan modeling by Alphafold 3.
AlphaFold 3 can accurately model glycans with proper stereochemistry only when using the BAP+CCD syntax, but manually creating these inputs is tedious and error-prone. To streamline the process, JAAG—a lightweight, user-friendly web tool—automates the conversion of glycans drawn by users into BAP+CCD syntax. This makes it easier for scientists to model glycoproteins and glycan–protein interactions, helping even AlphaFold 3 beginners generate reliable, stereochemically valid structures effortlessly.
The National Science Foundation (NSF) has announced a significant investment in biofoundries designed to advance synthetic biology and biotechnology across multiple research institutions. This initiative will establish facilities capable of integrating cutting-edge technologies like synthetic biology, machine learning, and laboratory automation. The goal is to accelerate innovations and develop sustainable biomanufacturing processes.
Among the newly funded projects is the NSF iBioFoundry at the University of Illinois Urbana-Champaign, which will focus on protein and cellular engineering, leveraging AI and automation to optimize synthetic biology research. These biofoundries will also serve as hubs for collaboration, engaging researchers, industry experts, and policymakers to address global scientific and engineering challenges.
Other biofoundries include the NSF Ex-FAB BioFoundry, which will explore organisms in extreme environments to advance biotechnology, and the NSF CREATE initiative aimed at democratizing biotechnology tools, particularly for underserved academic institutions. These investments reflect NSF’s commitment to enhancing scientific research and fostering educational opportunities in biotechnology and AI fields.
For more details on this NSF initiative, you can read further at and Mirage News.
O-GlcNAcylation is a dynamic post-translational modification involving the attachment of N-acetylglucosamine (GlcNAc) to serine or threonine residues on nuclear and cytoplasmic proteins. This process serves as a critical nutrient and stress sensor that influences a wide range of cellular functions, impacting processes such as transcription, protein degradation, and cellular signaling pathways.
The dynamic nature of O-GlcNAcylation is maintained through the interplay of two key enzymes: O-GlcNAc transferase (OGT), which adds the GlcNAc moiety, and O-GlcNAcase (OGA), which removes it. Because OGT’s activity is closely linked to cellular metabolic status, O-GlcNAcylation directly reflects changes in nutrient availability, such as fluctuations in glucose and other metabolites derived from the hexosamine biosynthetic pathway.
In response to cellular stress, O-GlcNAcylation often serves as a protective mechanism. During events like heat shock, oxidative stress, or hypoxia, the modification can stabilize proteins, enhance stress response pathways, and regulate the function of key transcription factors. For example, it has been shown to modulate the activity of tumor suppressor p53 and influence the circadian clock by regulating the core clock proteins, thereby linking metabolic cycles with timekeeping mechanisms in the cell.
Given its regulatory role in numerous physiological processes, dysregulation of O-GlcNAcylation has been implicated in various diseases, including diabetes, neurodegenerative disorders, and cancer. Elevated levels of O-GlcNAcylation are often observed in cancer cells, where they may support tumor growth by enhancing cell survival and proliferation. Conversely, reduced O-GlcNAcylation is associated with metabolic disorders like diabetes, underscoring the modification’s role as a metabolic sensor.
Research continues to explore the therapeutic potential of modulating O-GlcNAcylation to treat these conditions, with small molecules targeting OGT or OGA showing promise in preclinical studies. As scientists gain a deeper understanding of how this modification integrates metabolic and stress signals to regulate cellular physiology, it opens new avenues for intervention and the development of metabolic and neuroprotective therapies.
Chondroitin sulfate proteoglycans (CSPGs) play critical roles in various biological functions, particularly in regulating cellular processes in the nervous system. Their structural complexity arises from glycosaminoglycan (GAG) chains attached to core proteins, which makes understanding their structure-function relationships a scientific challenge. Recent advances have been made using solid-phase-supported chemoenzymatic synthesis to address these complexities and provide accurate tools for analysis.
The chemoenzymatic synthesis method employs a combination of solid-phase synthesis techniques and enzymatic modifications to construct glycopeptides that mimic natural CSPGs. This approach allows for precise control over the sulfation patterns and chain lengths of the glycosaminoglycans. Researchers use immobilized peptide resins to streamline the synthesis and ensure efficient enzymatic modification, resulting in a highly defined structure for subsequent analysis.
Advanced analytical techniques, such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry, are then used to characterize the synthesized glycopeptides. These methods confirm the structural integrity and provide insight into how different sulfation patterns affect biological activity, such as interactions with proteins or roles in cell signaling.
This solid-phase-supported chemoenzymatic strategy represents a significant advancement in glycoscience. It not only facilitates the production of structurally diverse CSPG mimics but also aids in deciphering the complex biological roles of glycosaminoglycans in processes like neurodevelopment and tissue repair. For more in-depth studies and applications, these methods pave the way for designing novel biomaterials and therapeutic agents targeting CSPG-related functions.
